14.09.2020 15:58:56
|
Stock Alert: Immunomedics Touches New High On Acquisition News
(RTTNews) - Shares of clinical-stage biopharmaceutical company Immunomedics, Inc. (IMMU) are surging more than 100% Monday morning on news of Gilead Sciences' agreement to buy Immunomedics for $88.00 per share, cash.
The stock touched a new high of $86.91 this morning.
The transaction, which values Immunomedics at approximately $21 billion, is expected to close during the fourth quarter of 2020.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Immunomedics Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |